Description: Reference Based Pricing (RBP) efforts have increased in popularity as tools to reduce the cost of care. Now with the ability to use CMS health plan transparency information, organizations can estimate the impact of savings from the use of RBP. This session will share the results of an analysis of this in the form of a case study.

Description: Over the past year, the life industry has seen the continued expansion of the Registered Index Linked Annuity (RILA) market. In this session we will take a deep dive into registered index linked products. We will explore common product features and mechanics, key risks, pricing, regulatory, and reserving considerations, and reasons why RILAs have been successful. We will also consider the potential impacts of the rising interest rate environment on product sales and design.

Description: Delve into the factors contributing to the rapid growth of high-cost medical treatments and how payers can manage the financial exposure that comes with them. Learn about the current and near-future state of million-dollar medical costs, as well as the trends shaping the industry. By attending the session, you will have a better understanding of the underlying drivers of high-cost treatments and will be equipped with practical strategies for mitigating their financial impact, including risk management techniques, cost containment measures, and new payment models. Additionally, you will be able to identify key considerations for implementing these strategies in their own organizations.

Description: To cope with the historically low-interest rate environment that we recently experienced, there has been a growing trend among life insurers' investment portfolios to allocate to such alternative assets as collateralized loan obligations (CLOs), rated feeder funds, and collateralized fund obligations (CFOs). In this session, you will gain an overview of alternative assets as we work through answering the following: - What are alternative assets? - Why do insurers invest in alternative assets? - What are the risks of alternative assets? - History of alternatives: How did we get here? - What is currently in the portfolios? - What are the concerns within and outside the industry (without a debate about the concerns)? - What should actuaries be aware of and what role do actuaries play in evaluating portfolio risks?

Description: "Examine the impact of traditional deductibles on health care equity and the need for innovative plan designs. You will learn about the limitations of consumer-driven health care costs broadly today, as well as alternative cost-sharing approaches that have been successful in driving consumerism without exposing members to high costs. By attending the session, you will be able to: Have a clearer understanding of the issues surrounding deductibles Be equipped with practical ideas for creating more equitable and effective cost-sharing solutions Assess the feasibility and potential impact of implementing these solutions for your own organization"

Description: This session reviews the importance of using benchmarks in healthcare utilization management to improve organizational and patient outcomes and increase efficiency. It highlights how benchmarks can inform decisions about utilization management strategies and benefit members, payers, and providers. The presentation includes best practices, successful examples, and solutions to challenges, focusing on claim utilization, risk adjustment efficiency, quality metrics, and overall performance. Additionally, insights into the future of benchmarks and the value of analyzing the entire distribution of data for deeper insights will be shared.

Description: Explore cutting-edge advancements in virtual care, including remote patient monitoring and care delivery in the metaverse, which build on the foundation that pandemic-era telehealth built. Gain a deep understanding of how these innovations are set to shape the future of telehealth and healthcare more broadly. By attending the session, you will be equipped with a roadmap of the key trends and opportunities in virtual care, and be able to identify potential challenges and solutions for their own organizations in leveraging these new tools.

Description: In this interactive presentation, you will learn how people make decisions and how this can lead to errors in judgement and irrational choices.

Description: Given the rise in interest rates during 2022, join an insightful discussion on the implications of increasing rates on fixed annuity (FA) and fixed index annuity (FIA) business by looking at industry experience for FA and FIA products for 2022 compared to earlier years. Additionally, you will walk through partial withdrawals, guaranteed lifetime withdrawal benefit (GLWB) utilization, mortality and what to expect as interest rate volatility continues.

Description: "Direct medical costs for cancer care topped $209 billion nationally in 2020, accounting for a significant proportion of all health care expenditures in the U.S. Indirect costs are also significant, encompassing loss of productivity, wages, leisure time and decreased quality of life. The way cancer programs deliver and are reimbursed for care is rapidly changing. As the cost of cancer care continues to rise, several new value-based care programs - both public and private - have attempted to curb these rising costs. Learn about the current landscape of VBC oncology programs, several key challenges and opportunities with oncology analytics, as well as anticipated evolution of cancer care in the near future. Topics include: Current VBC oncology landscape, including a more detailed discussion on CMS' latest oncology program, Enhancing Oncology Model (EOM) Discussion on current challenges and opportunities with oncology analytics, including some advanced methodologies that have been developed based on documented clinical pathways to better understand cost drivers Future state of oncology care including emerging pharmaceuticals and novel therapies, personalized care regimens, and other clinical innovations"